Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure

Summary: in the present-day routine clinical practice, measurement of GFR in the absence of risk factors for the development of CKD is not common. However, recent research shows that evaluation of GFR in patients with NAFLD is imperative even in the absence of classical risk factors for CKD. Early d...

Full description

Bibliographic Details
Main Authors: O. M. Drapkina, E. V. Zyatenkova
Format: Article
Language:Russian
Published: Remedium Group LLC 2015-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/347
id doaj-4787dbd0921e46b8909822487b8419aa
record_format Article
spelling doaj-4787dbd0921e46b8909822487b8419aa2021-07-28T13:29:21ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902015-12-0101311812310.21518/2079-701X-2015-13-118-123347Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failureO. M. Drapkina0E. V. Zyatenkova1National Research Center for Preventive Medicine, MoscowFirst Moscow State Medical University named after I.M. SechenovSummary: in the present-day routine clinical practice, measurement of GFR in the absence of risk factors for the development of CKD is not common. However, recent research shows that evaluation of GFR in patients with NAFLD is imperative even in the absence of classical risk factors for CKD. Early detection of kidney damage in patients with CHF and NAFLD will enable to define the right dose of pharmacotherapy and avoid overdose.https://www.med-sovet.pro/jour/article/view/347хсннажбпфиброз печенистеатоз печени скфхроническая болезнь почекn-терминальный пропептид коллагена iii типаfatty liver indexnafld fibrosis score
collection DOAJ
language Russian
format Article
sources DOAJ
author O. M. Drapkina
E. V. Zyatenkova
spellingShingle O. M. Drapkina
E. V. Zyatenkova
Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure
Медицинский совет
хсн
нажбп
фиброз печени
стеатоз печени скф
хроническая болезнь почек
n-терминальный пропептид коллагена iii типа
fatty liver index
nafld fibrosis score
author_facet O. M. Drapkina
E. V. Zyatenkova
author_sort O. M. Drapkina
title Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure
title_short Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure
title_full Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure
title_fullStr Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure
title_full_unstemmed Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure
title_sort renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2015-12-01
description Summary: in the present-day routine clinical practice, measurement of GFR in the absence of risk factors for the development of CKD is not common. However, recent research shows that evaluation of GFR in patients with NAFLD is imperative even in the absence of classical risk factors for CKD. Early detection of kidney damage in patients with CHF and NAFLD will enable to define the right dose of pharmacotherapy and avoid overdose.
topic хсн
нажбп
фиброз печени
стеатоз печени скф
хроническая болезнь почек
n-терминальный пропептид коллагена iii типа
fatty liver index
nafld fibrosis score
url https://www.med-sovet.pro/jour/article/view/347
work_keys_str_mv AT omdrapkina renaldiseaseinpatientswithnonalcoholicfattyliverdiseaseandchronicheartfailure
AT evzyatenkova renaldiseaseinpatientswithnonalcoholicfattyliverdiseaseandchronicheartfailure
_version_ 1721274466123644928